This report details clinical, necropsy, and pedigree data on an inherited, lethal, neurologic disease of young Gordon Setters. This disorder is characterized by an early age of onset, gait and postural abnormalities, progressive weakness, and recumbency by 5-6 weeks of age. Although clinically distinctive, postmortem changes in affected pups were minimal. Gross lesions were not observed. Microscopic changes were subtle and consisted of astrocyte swelling, primarily in the cerebrocortical and cerebellar white matter, and white matter tracts of the brainstem. Immunohistochemistry for glial fibrillary acidic protein revealed a marked increase in the number and staining intensity of astrocyte cytoplasmic processes in affected pups compared with agematched controls. Neither cerebral inflammation nor neuronal necrosis was identified. Pedigree analysis of affected litters demonstrated an autosomal recessive mode of inheritance. A diagnosis of this heritable disease should be based on the early age of onset (3-4 weeks of age), characteristic clinical signs, rapid progression to recumbency by 5-6 weeks of age, identification of swollen astrocytes primarily in the cerebellar and cerebrocortical white matter and white matter tracts of the brainstem, and the exclusion of other disease processes.
however, failure to generate any response may indicate that NWC isolate is more similar to pestiviruses in species other than bovine. In a camel isolate 10 classified as a cytopathic Type II BVDV, similarity was noted to a border disease isolate in sheep. The BVDV has been isolated from deer, with the isolates having sequences different from bovine isolates yet more closely resembling Type I than Type II isolates. 4 It is interesting that one of our isolates was a cytopathic and the other a noncytopathic biotype. condition has not been previously described in the veterinary literature. This report details clinical, necropsy, and pedigree data on this unique disorder.
Three Gordon Setter puppies from a litter of 8 were submitted to the Iowa State University Veterinary Diagnostic Laboratory. The breeders of these puppies reported that they had appeared normal until approximately 3 weeks of age, at which time all 3 had begun exhibiting abnormal locomotion and posture. Affected pups had appeared stiff, trembled, would stagger, and occasionally fall over. Their heads were carried low and slightly rotated. Affected pups would occasionally walk into objects. These clinical signs had initially been intermittent. As the condition progressed, the pups began to cry, at times incessantly. The puppies became weaker and lost muscle tone, particularly in the pelvic limbs. One puppy was submitted at 4½ weeks of age. This animal was in sternal recumbancy, could move all 4 limbs, had pain perception in all 4 limbs, but would not stand. A menace response was present. The 2 remaining affected puppies were submitted at 5½ weeks of age. These animals were presented in lateral recumbancy, could move all 4 limbs, had pain perception in all 4 limbs, but could not stand or remain sternal. Neither animal had a menace response.
Complete blood counts and serum chemistry profiles on these 3 animals were within normal limits. All 3 pups were slightly thin. The 2 euthanized at 5½ weeks of age had symmetrical atrophy of pelvic limb musculature.
Microscopic changes were subtle, confined to the brain and spinal cord, and consisted of individual astrocytes or small, often linear groups of astrocytes, with swollen, welldemarcated, cytoplasmic borders. Swollen astrocytes were identified primarily in the cerebrocortical and cerebellar white matter, white matter tracts of the brainstem, and occasionally in the gray matter of the spinal cord. Neither inflammation nor neuronal necrosis was observed.
Fresh and fixed brain and cerebral spinal fluid (CSF) were obtained from 3 additional Gordon Setter puppies from an unrelated litter of 11. These puppies had also begun exhibiting abnormal locomotion and posture at approximately 3 weeks of age. Clinical signs and disease progression were similar to the affected puppies described above. These pups were euthanized at 4 weeks of age. The CSF was collected by the submitting veterinarian prior to euthanasia. The CSF electrolyte levels in these 3 pups were within normal limits. Histologic lesions in the brains of these puppies were indistinguishable from the changes identified in the first litter. Microscopic or ultrastructural changes suggestive of a neuronal storage disease or myopathy were not identified.
Immunohistochemistry for glial fibrillary acidic protein (GFAP) was employed to better define the astrocyte changes in all 6 of these puppies. Cerebral sections from four 4-5week-old puppies submitted to the diagnostic lab for conditions not referable to the central nervous system (CNS) and in which CNS lesions were not identified were stained with GFAP and used as age-matched controls. The number of astrocyte cytoplasmic processes stained with GFAP appeared markedly increased in affected individuals compared with similar anatomic locations in age-matched controls (Fig. 1 ). The increased GFAP staining in affected pups appeared to be the result of an increase in the number of thick, intensely staining processes rather than expansion of perikaryal cytoplasm or an increase in the number of astrocytes. In one litter in which puppies were necropsied at different ages, there appeared to be greater numbers of GFAP-stained processes in pups necropsied at 5½ weeks of age compared with their 4½-week-old sibling.
In all 6 pups, increased GFAP staining was most consistently identified in the cortical white matter and granular layer of the cerebellum and in virtually all of the white mattered tracts of the brainstem, particularly the middle cerebellar peduncle and pyramidal tract. Increased staining of the optic nerve was also identified. Image analysis was uti-lized to quantify these subjective assessments. Images were captured using a Sony DXC-3000A color video camera and were analyzed with Visilog software by Noesis. a In affected pups, the average percent area stained with GFAP in 5 randomly chosen, 500ϫ fields of cerebellar cortical white matter was 11.04% Ϯ 0.67 (SE), whereas only 4.26% Ϯ 0.97 (SE) of the area was stained in the age-matched controls. This nearly threefold increase in the amount of GFAP staining was statistically significant (P Ͻ 0.00005). In analyzed images, there was no significant difference in the average number of astrocyte cell bodies between groups.
Pedigree information was obtained on Gordon Setter litters with individuals exhibiting clinical signs and disease progression as described above. Six affected litters were identified in a single kennel. Several of these litters were the product of test matings to try and determine whether this disorder was a heritable condition (Fig. 2) .
Ten litters with a total of 84 pups were recorded in which there was reliable information on affected and unaffected individuals. Twenty-seven affected pups were identified (32.1%), of which 13 (48%) were male and 14 were female (52%). Despite intensive care, all affected pups had died or were euthanized in a moribund state. As none of the parents had clinical signs and affected males and females were represented in nearly equal numbers, it was assumed that this condition was an autosomal recessive disorder and that litters with affected animals resulted from the mating of two carriers. A chi-square test was used to determine if the number of affected individuals significantly exceeded the expected ratio of 3/4 normal and 1/4 affected, as would be anticipated with an autosomal recessive trait. Each litter was tested individually and the chi-square values summed across the litters. No litter chi-square value exceeded 1.2, and the total chi-square value was far below the significance threshold. Statistical analysis of pedigree data was consistent with an autosomal recessive mode of inheritance.
This heritable, lethal, neurologic disorder of Gordon Setters is characterized by an early age of onset and initially by gait and postural abnormalities. Affected pups become progressively weaker, cry incessantly, and are recumbent by 5-6 weeks of age. Although clinically distinctive, this disease may be a diagnostic challenge for the pathologist because there are no specific gross lesions and microscopic changes are subtle in routine HE-stained sections. Unless adequate clinical information is provided to heighten suspicion, GFAP stains may not be undertaken to visualize the increase in the number of intensely stained astrocyte cytoplasmic processes. A diagnosis of this heritable disease should be based on the following criteria: a) early age of onset (3-4 weeks of age), b) characteristic clinical signs (pups exhibit crooked necks and carry heads low, stiffened posture, and staggering gait; appear blind; begin to cry, often incessantly; lose muscle tone and the ability to stand), c) progression to recumbency by 5-6 weeks of age, d) multiple pups generally affected in each litter, e) identification of swollen astrocytes primarily in the cerebellar and cerebrocortical white matter and white matter tracts of the brainstem, f) identification of increased numbers of GFAP-stained astrocyte cytoplasmic processes (this lesion is most readily visualized in the cortical white matter and granular layer of the cerebellum), and g) exclusion of other disease processes.
The primary microscopic change observed in sections of brain was astrocyte swelling. This change was most readily identified in the cerebrocortical and cerebellar white matter and white matter tracts of the brainstem. Image analysis of these segments of brain documented a nearly threefold increase in the amount of GFAP staining in affected pups compared with age-matched controls. This difference was readily appreciated without the use of imaging techniques but required GFAP-stained cerebral sections from similar-aged pups for comparison. Differences in GFAP staining appeared to be due to an increase in the number of intensely staining cytoplasmic processes and was not due to an increase in the number of astrocytes.
In 1 litter, 2 pups were necropsied a week after their affected sibling. These older pups with more advanced clinical signs appeared to have increased numbers of GFAP-stained processes. Although this subjective assessment was made on a very limited number of animals and may not prove to be a consistent change, this observation suggests the possibility that there may be a correlation between astrocyte changes and the severity of clinical signs and that astrocyte changes may be minimal in pups necropsied early in the course of disease. A systematic and sequential evaluation of GFAPstained sections comparing affected and unaffected littermates would help to further define the astrocyte changes. Unfortunately, unaffected littermates were not available for examination.
Although astrocyte swelling was the most striking histologic change, this does not necessarily imply that the disease is the result of primary astrocyte dysfunction. Astrocyte swelling and/or hypertrophy is a common reactive change in a variety of neurologic disorders including hypoxia, hyperammonemia, hypoglycemia, epilepsy, and trauma. 3 The increase in the number, complexity, and GFAP staining of astrocyte processes in the brains of affected pups could represent reactive astrocyte hypertrophy.
The pathogenesis of this condition is unknown. A literature review failed to uncover reports of a similar syndrome in other breeds, domestic species, or humans. Microscopic or ultrastructural changes indicative of a neuronal storage disease or myopathy were not identified. The clinical signs and lesions in these pups were distinct from cerebellar cortical abiotrophy (CCA), which has been described as an autosomal recessive trait in Gordon Setters. Cerebral cortical abiotrophy becomes clinically apparent between 6 and 10 months of age, is slowly progressive, and is characterized by truncal ataxia, increased tone of the extensor musculature, and nystagmus. 1, 2, 4 Lesions are confined to the cerebellum and consist of atrophy and loss of Purkinje cells and granule cells. 1, 2, 4 Although some of the gait and postural abnormalities observed in affected pups suggest possible cerebellar involvement, neuronal changes in the cerebellum were not identified, and the age of onset and clinical course was distinct from CCA.
Autosomal recessive disorders may emerge in a population as the prevalence of a deleterious gene or degree of consanguinity increases. Pedigree analysis and breeding trials demonstrate that this disorder is an autosomal recessive trait, which marks both parents and two thirds of surviving offspring as carriers. A test to identify carriers has not been developed. In order to decrease the prevalence of this gene in the breed, the parents and siblings of affected pups should be excluded from the breeding population unless test matings are used to determine that individual siblings are not carriers.
